Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 12;1(1):9-18.
doi: 10.1159/000489032. eCollection 2018 Jun.

Determination of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol with Gas Chromatography-Mass Spectrometry: Analytical and Preanalytical Challenges and Pitfalls

Affiliations

Determination of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol with Gas Chromatography-Mass Spectrometry: Analytical and Preanalytical Challenges and Pitfalls

Christian Lanz et al. Med Cannabis Cannabinoids. .

Abstract

Background: The endocannabinoids anandamide (N-arachidonoyl ethanolamide [AEA]) and 2-arachidonoyl glycerol (2-AG) are involved in the regulation of neuronal, immune, metabolic, vascular, and reproductory functions.

Methods: The development and validation of an analytical method for the determination of AEA and 2-AG in human plasma based on liquid-liquid extraction and gas chromatography-mass spectrometry after silylation is described and (pre)-analytical pitfalls are identified.

Results: In contrast to 2-AG, AEA was unstable in whole blood and increased by a factor of 2.3 within 3 h on ice. AEA was stable in plasma on ice for 4 h while 2-AG tended to decrease. Excellent stability at room/ambient temperature was found for both derivatized compounds over 45 h. Furthermore, 3 freeze-thaw cycles revealed a complex pattern: endogenous AEA was stable in plasma but slightly increased in spiked samples (+12.8%), while endogenous 2-AG concentrations increased by 51% and declined by 24% in spiked samples. A long-term study over 4 weeks at -80°C showed that low endogenous AEA and spiked 2-AG concentrations were stable. However, spiked AEA tended to increase (+19%) and endogenous 2-AG significantly increased by 50% after 2 weeks. Food intake 2 h before blood collection showed no effect on AEA concentrations, whereas 2-AG increased significantly by a factor of 3.

Conclusions: Overall, limited in vitro and/or in vivo/ex vivo chemical stability of endocannabinoids has to be taken into account.

Keywords: 2-Arachidonoyl glycerol; Anandamide; Endocannabinoids; Gas chromatography-mass spectrometry; Human plasma; Pitfalls.

PubMed Disclaimer

Conflict of interest statement

The authors have declared no conflict of interest.

Figures

Fig. 1
Fig. 1
Gas chromatography-mass spectrometry chromatograms obtained in selected ion monitoring mode with the plasma of a healthy volunteer with concentrations of AEA and AG being 0.69 and 1.98 ng/mL, respectively (a), and pooled plasma spiked with AEA and 2-AG at 3 ng/mL (total concentrations of AEA and AG: 3.57 and 3.52 ng/mL, respectively) (b). For AEA m/z 420.2 is depicted as the quantifier ion (to the left of the dotted line), whereas m/z 433.2 is shown for 2-AG and 1-AG (to the right of the dotted line). For experimental conditions, see online supplementary material. AEA, anandamide; AG, arachidonoyl glycerol.
Fig. 2
Fig. 2
Stability of AEA (black bars) and AG (grey bars) in whole blood. Depicted are mean values + SD of EC concentrations from plasma samples of 3 individuals. Blood samples were kept on ice for 15, 75, and 195 min, referred to as sampling time points 1, 2, and 3, respectively, before centrifugation to obtain plasma. AEA, anandamide; AG, arachidonoyl glycerol; EC, endocannabinoid. * p < 0.05.
Fig. 3
Fig. 3
Benchtop stability over 4 h (a) and autosampler stability over 45 h (b) of AEA (black bars) and AG (grey bars) in plasma spiked with AEA and 2-AG at 3 ng/mL. Depicted are mean values + SD of total EC concentrations of 3 samples prepared in the same plasma for each time point. AEA, anandamide; AG, arachidonoyl glycerol; EC, endocannabinoid.
Fig. 4
Fig. 4
Freeze-thaw stability of AEA (black bars) and AG (grey bars) over 3 cycles obtained with pooled blank plasma (a) and the same plasma spiked with AEA and 2-AG at 3 ng/mL (b). Depicted are mean values + SD of 3 samples. Total EC concentrations are given for the spiked samples. AEA, anandamide; AG, arachidonoyl glycerol; EC, endocannabinoid. * p < 0.05 compared with the concentrations at the beginning (cycle 0).
Fig. 5
Fig. 5
Long-term stability of AEA (black bars) and AG (grey bars) before and 2 and 4 weeks after storing the samples at −80°C obtained with pooled blank plasma (a) and the same plasma spiked with AEA and 2-AG at 3 ng/mL (b). Mean values + SD of 3 samples are presented for each time point. Total EC concentrations are given for the spiked samples. AEA, anandamide; AG, arachidonoyl glycerol; EC, endocannabinoid. * p < 0.05 compared with the concentrations at the beginning (before freezing).
Fig. 6
Fig. 6
Influence of food intake on AEA (black bars) and AG (grey bars) plasma concentrations. Depicted are mean values + SD of fasting EC concentrations obtained from 5 healthy subjects (fasting) and the EC concentrations measured from the same subjects 2 h after a regular lunch (postprandial). AEA, anandamide; AG, arachidonoyl glycerol; EC, endocannabinoid. * p < 0.05.

Similar articles

Cited by

References

    1. Hanus LO. Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids. Med Res Rev. 2009;29:213–271. - PubMed
    1. Howlett AC. Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds. Life Sci. 1984;35:1803–1810. - PubMed
    1. Howlett AC, Fleming RM. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol Pharmacol. 1984;26:532–538. - PubMed
    1. Devane WA, Dysarz FA, 3rd, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol. 1988;34:605–613. - PubMed
    1. Gerard CM, Mollereau C, Vassart G, Parmentier M. Nucleotide sequence of a human cannabinoid receptor cDNA. Nucleic Acids Res. 1990;18:7142. - PMC - PubMed